Risk Exposure

As the culmination of the project, ALCOVE will provide information on the exposure of patients living with dementia to antipsychotics in Europe.

An operational set of tools and methods for the measurement of the risk exposure based on the European benchmarking performed by ALCOVE will be proposed and will be freely available at the end of the project on the ALCOVE website.